Company intelligence / Profile preview

Zest Science

Ownership: Private
Development stage: Commercial

Overview

Zest Science provides direct-to-consumer longevity supplements and personalized health optimization programs. Their approach combines biomarker tracking with targeted nutraceuticals and lifestyle interventions to address biological aging factors such as inflammation, metabolic dysfunction, hormone imbalance, cognitive decline, sleep disruption, and fertility issues. No clinical trial data is published; efficacy claims are based on scientific literature supporting ingredients like NMN.

Therapeutic areas: OtherMetabolic DisordersNeurologyWomen's Health
Modalities: Small moleculeNutraceuticals/SupplementsNon-pharmacological therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on Zest Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zest Science.

Explore the full profile